Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Heart Failure Reports
Published in: Current Heart Failure Reports 3/2015

01-06-2015 | Self-Care and Health Outcomes (T Jaarsma, Section Editor)

Patient-Reported Outcomes in Heart Failure: Existing Measures and Future Uses

Authors: Lauren E. Thompson, David B. Bekelman, Larry A. Allen, Pamela N. Peterson

Published in: Current Heart Failure Reports | Issue 3/2015

Login to get access

Abstract

Patient-reported outcomes (PROs) are any report obtained directly from a patient about how they feel or function in relation to their health condition and its therapies. Strong support for PROs exists at multiple levels of the health-care community from regulatory boards to clinical researchers. PROs are particularly important in heart failure because it is a common chronic illness marked with acute exacerbations, often requiring hospitalization, and significant symptom burden. Use of PROs to understand patient perspectives will help providers deliver more patient-centered care, and thus improve the quality of care. This review provides a contemporary overview of the current state of PROs in heart failure and suggests future directions and opportunities to advance PRO use to provide more comprehensive care. Advancing PRO measurement along with incorporating longitudinal measures in national databases and local electronic health records will serve to improve patient-centered care for patients with heart failure.
Literature
1.
Higgins, Julian PT, ed. Cochrane handbook for systematic reviews of interventions. vol. 5. Chichester: Wiley-Blackwell, 2008.
2.
Go AS et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.CrossRefPubMed
3.
Patrick DL et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10 Suppl 2:S125–37.CrossRefPubMed
4.
5.
Fan X, Lee KS, Frazier SK, Lennie TA, Moser DK. Psychometric testing of the Duke Activity Status Index in patients with heart failure. Eur J Cardiovasc Nurs. 2014. doi:10.​1177/​1474515114523354​.
6.
Hlatky MA et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64(10):651–4.CrossRefPubMed
7.
8.
Rector T, Kubo S, Cohn J. Patients’ self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail. 1987;3(5):198–209.
9.
Green CP et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245–55.CrossRefPubMed
10.
Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed
11.
12.
Derogatis LR et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.CrossRefPubMed
13.
Cella DF et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed
14.
Brucker PS et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28(2):192–211.CrossRefPubMed
15.
Whoqol S. A cross-cultural study of spirituality, religion, and personal beliefs as components of quality of life. Soc Sci Med. 2006;62:1486–97.CrossRef
16.
Bennett SJ et al. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung. 1997;26(4):273–9.CrossRefPubMed
17.
Bennett SJ et al. Reliability and validity of the compliance belief scales among patients with heart failure. Heart Lung. 2001;30(3):177–85.CrossRefPubMed
18.
Bentley B et al. Demonstration of psychometric soundness of the Dietary Sodium Restriction Questionnaire in patients with heart failure. Heart Lung. 2009;38(2):121–8.CrossRefPubMed
19.
Lennie TA et al. Relationship of heart failure patients’ knowledge, perceived barriers, and attitudes regarding low-sodium diet recommendations to adherence. Prog Cardiovasc Nurs. 2008;23(1):6–11.CrossRefPubMed
20.
Riegel B, Carlson B, Glaser D. Development and testing of a clinical tool measuring self-management of heart failure. Heart Lung J Acute Crit Care. 2000;29(1):4–15.CrossRef
21.
Baker DW et al. A telephone survey to measure communication, education, self-management, and health status for patients with heart failure: the Improving Chronic Illness Care Evaluation (ICICE). J Card Fail. 2005;11(1):36–42.CrossRefPubMed
22.
Baker DW et al. Differences in education, knowledge, self-management activities, and health outcomes for patients with heart failure cared for under the chronic disease model: the improving chronic illness care evaluation. J Card Fail. 2005;11(6):405–13.CrossRefPubMed
23.
Jaarsma T et al. The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable and valid international instrument. Eur J Heart Fail. 2009;11(1):99–105.CrossRefPubMed
24.
Brehaut JC et al. Validation of a decision regret scale. Med Decis Mak. 2003;23(4):281–92.CrossRef
25.
Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed
26.
27.
Rumsfeld JS. Health status and clinical practice: when will they meet? Circulation. 2002;106(1):5–7.CrossRefPubMed
28.
Spertus JA et al. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone’s neuroHormonal efficacy and survival study). Am Heart J. 2002;143(4):636–42.CrossRefPubMed
29.••
Rumsfeld JS et al. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013;127(22):2233–49. Comprehensive review of patient-reported health status measures, with emphasis on future uses and implementation.CrossRefPubMed
30.
Calkins DR et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991;114(6):451–4.CrossRefPubMed
31.
Heidenreich PA et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47(4):752–6.CrossRefPubMed
32.
Mommersteeg PMC et al. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J. 2009;157(2):208–18.CrossRefPubMed
33.
Chan PS et al. Patient health status and costs in heart failure: insights from the eplerenone post–acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation. 2009;119(3):398–407.CrossRefPubMed
34.
Rector TS et al. Use of the living with heart failure questionnaire to ascertain patients’ perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1(3):201–6.CrossRefPubMed
35.
Tsevat J et al. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized elderly longitudinal project. JAMA. 1998;279(5):371–5.CrossRefPubMed
36.
Lewis EF et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20(9):1016–24.CrossRefPubMed
37.
Brunner-La Rocca HP et al. End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J. 2012;33(6):752–9.CrossRefPubMed
38.
Kraai IH et al. Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail. 2013;15(10):1113–21.CrossRefPubMed
39.
Yancy CW et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240–327.CrossRefPubMed
40.•
41.
Members WC et al. ACCF/AHA/AMA-PCPI 2011 Performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association–Physician Consortium for Performance Improvement. Circulation. 2012;125(19):2382–401.CrossRef
42.
Anker SD et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014;35(30):2001–9.CrossRefPubMed
43.••
Frank L et al. The PCORI perspective on patient-centered outcomes research. JAMA. 2014;312(15):1513–4. Explanation of PCORI goals for the future as well as a reivew of current grant selection process.CrossRefPubMed
44.
45.
Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: National Academy Press; 2001.
46.
Zannad F et al. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013;15(10):1082–94.CrossRefPubMed
47.
Eton DT et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.CrossRefPubMedCentralPubMed
48.
Spertus JA. Evolving applications for patient-centered health status measures. Circulation. 2008;118(20):2103–10.CrossRefPubMed
49.
US Department of Health and Human Services, FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes. 2006;4:79. doi:10.​1186/​1477-7525-4-79.
50.
Dyer MT et al. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8(13):1–12.
51.
52.
Nowels D et al. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res. 2005;14(1):95–105.CrossRefPubMed
53.
Anker SD et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436–48.CrossRefPubMed
54.
Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017–25.CrossRefPubMed
55.
Guyatt GH et al. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med. 1989;4(2):101–7.CrossRefPubMed
56.
Wiklund I et al. Self-assessment of quality of life in severe heart failure: an instrument for clinical use. Scand J Psychol. 1987;28(3):220–5.CrossRefPubMed
57.
Zambroski CH et al. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198–206.CrossRefPubMed
58.
Hawthorne G et al. Deriving utility scores from the SF-36 health instrument using Rasch analysis. Qual Life Res. 2008;17(9):1183–93.CrossRefPubMed
59.
Cella D et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRefPubMedCentralPubMed
60.
Raphael C et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–82.CrossRefPubMedCentralPubMed
61.
Tate 3rd CW et al. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). J Card Fail. 2007;13(9):732–7.CrossRefPubMed
62.
Flynn KE et al. Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure. Am Heart J. 2012;163(1):88.e3–94.e3.CrossRef
63.
Kosiborod M et al. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007;115(15):1975–81.CrossRefPubMed
64.
Spertus J et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150(4):707–15.CrossRefPubMed
65.
66.
Luther SA et al. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005;11(6):414–21.CrossRefPubMed
67.
Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee. American Journal of Cardiology. 1995;75(17):1220–3.
68.
69.
Schiffer AA et al. Health status in patients treated with cardiac resynchronization therapy: modulating effects of personality. Pacing Clin Electrophysiol. 2008;31(1):28–37.CrossRefPubMed
70.
Mark DB et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Ann Intern Med. 2014;161(6):392–9.CrossRefPubMedCentralPubMed
71.
Nesbitt T et al. Correlates of quality of life in rural heart failure patients. Circ Heart Fail. 2014;7:882–7.CrossRefPubMed
72.
Edelman JJ et al. Percutaneous mitral valve repair in a high-risk Australian series. Heart Lung Circ. 2014;23(6):520–6.CrossRefPubMed
73.
Filippatos G et al. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail. 2013;15(11):1267–76.CrossRefPubMedCentralPubMed
74.
Kerrigan DJ, Williams CT, Ehrman JK, Saval MA, Bronsteen K, Schairer JR, Swaffer M, Brawner CA, Lanfear DE, Selektor Y, Velez M, Tita C, Keteyian SJ. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the Rehab-VAD randomized controlled trial. JACC Heart Failure. 2014;2(6):653–9.
75.
Costanzo MR et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49(6):675–83.CrossRefPubMed
76.
St John Sutton MG et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107(15):1985–90.CrossRefPubMed
77.
Xiong GL et al. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. Circ Heart Fail. 2012;5(6):688–92.CrossRefPubMedCentralPubMed
78.
Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39(9):1414–21.CrossRefPubMed
79.
McMurray JJV et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004.CrossRefPubMed
80.
Reynolds MR et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124(18):1964–72.CrossRefPubMed
81.
Bekelman DB et al. Patient-centered disease management (PCDM) for heart failure: study protocol for a randomised controlled trial. BMC Cardiovasc Disord. 2013;13:49.CrossRefPubMedCentralPubMed
82.
Allen LA et al. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4(4):389–98.CrossRefPubMedCentralPubMed
83.
Conard MW et al. Patient-reported economic burden and the health status of heart failure patients. J Card Fail. 2006;12(5):369–74.CrossRefPubMed
84.
Sandau KE et al. A conceptual definition of quality of life with a left ventricular assist device: results from a qualitative study. Heart Lung. 2014;43(1):32–40.CrossRefPubMed
85.
Modica M, Ferratini M, Torri A, Oliva F, Martinelli L, De Maria R, et al. Quality of Life and Emotional Distress Early After Left Ventricular Assist Device Implant: A Mixed-Method Study. Artificial Organs. 2014. doi:10.​1111/​aor.​12362.
86.
McIlvennan CK et al. Decision making for destination therapy left ventricular assist devices: “there was no choice” versus “I thought about it an awful lot”. Circ Cardiovasc Qual Outcomes. 2014;7(3):374–80.CrossRefPubMed
87.
McIlvennan CK, Allen LA. To DT or not to DT, that is the question: working toward a comprehensive, patient-centered perspective on left ventricular assist device for destination therapy. Circ Cardiovasc Qual Outcomes. 2014;7(1):13–4.CrossRefPubMed
88.
Brouwers C et al. Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail. 2011;4(6):714–23.CrossRefPubMed
89.
90.
91.
92.
93.
Macabasco-O’Connell A et al. Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. J Gen Intern Med. 2011;26(9):979–86.CrossRefPubMedCentralPubMed
94.
Peterson PN et al. Health literacy and outcomes among patients with heart failure. JAMA. 2011;305(16):1695–701.CrossRefPubMed
95.
Joyce KE et al. Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy. J Interv Card Electrophysiol. 2013;36(2):185–97.CrossRefPubMed
96.
97.
Luttik ML et al. The objective burden in partners of heart failure patients; development and initial validation of the Dutch Objective Burden Inventory. Eur J Cardiovasc Nurs. 2008;7(1):3–9.CrossRefPubMed
98.
Vellone E et al. Validity and reliability of the caregiver contribution to self-care of heart failure index. J Cardiovasc Nurs. 2013;28(3):245–55.CrossRefPubMed
99.
Burke RE et al. Caregivers’ perceived roles in caring for patients with heart failure: what do clinicians need to know? J Card Fail. 2014;20(10):731–8.CrossRefPubMed
Metadata
Title
Patient-Reported Outcomes in Heart Failure: Existing Measures and Future Uses
Authors
Lauren E. Thompson
David B. Bekelman
Larry A. Allen
Pamela N. Peterson
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Heart Failure Reports / Issue 3/2015
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-015-0253-9

Other articles of this Issue 3/2015

Current Heart Failure Reports 3/2015 Go to the issue

Decompensated Heart Failure (JE Ho, Section Editor)

Venous Congestion, Endothelial and Neurohormonal Activation in Acute Decompensated Heart Failure: Cause or Effect?

Comorbidities of Heart Failure (CE Angermann, Section Editor)

Cellular Immunity and Cardiac Remodeling After Myocardial Infarction: Role of Neutrophils, Monocytes, and Macrophages

Management of Heart Failure (T Meyer, Section Editor)

Small Steps for Idiopathic Giant Cell Myocarditis

Self-Care and Health outcomes (T Jaarsma, Section Editor)

Tailoring of Self-Management Interventions in Patients With Heart Failure

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Is There a Role for Invasive Hemodynamic Monitoring in Acute Heart Failure Management?

Pharmacologic Therapy (W H W Tang, Section Editor)

Utilizing Cardiac Biomarkers to Detect and Prevent Chemotherapy-Induced Cardiomyopathy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits